The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 trial of ruxolitinib, lenalidomide, and methylprednisolone for relapsed/refractory multiple myeloma patients.
 
James R. Berenson
Employment - Amgen; Bristol-Myers Squibb; Celgene; Incyte; Janssen; Takeda
Stock and Other Ownership Interests - OncoTracker
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Incyte; Janssen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Incyte; Janssen; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Incyte; Janssen; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Incyte; Janssen; Takeda
Patents, Royalties, Other Intellectual Property - OncoTacker
Expert Testimony - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
 
Jennifer To
No Relationships to Disclose
 
Tanya M. Spektor
No Relationships to Disclose
 
Carley Turner
No Relationships to Disclose
 
Regina A. Swift
No Relationships to Disclose
 
Benjamin M Eades
No Relationships to Disclose
 
Gary Schwartz
No Relationships to Disclose
 
Shahrooz Eshaghian
No Relationships to Disclose
 
Laura Stampleman
No Relationships to Disclose
 
Robert A. Moss
No Relationships to Disclose
 
Stephen Lim
Employment - Pathway Genomics
 
Robert A. Vescio
No Relationships to Disclose